To understand the molecular mechanism by which LIFR inhibitor EC359 diminishes cell viability of OCa cells, we profiled gene expression changes upon EC359 treatment using global RNA-seq analysis. The gene discussed is LIFR; the disease is oculocutaneous albinism.